Target intelligence / Profile preview

Cell cycle progression protein 1 (CCPG1)

Target
CCPG1
Molecular classification
Other (ER-phagy receptor), Transmembrane protein
01

Overview

Cell cycle progression protein 1 (CCPG1) is a vertebrate-specific ER membrane protein serving as a bispecific receptor for selective autophagy of the endoplasmic reticulum (ER-phagy)[1][2]. It contains a large ER luminal region (>500 amino acids) harboring multiple highly conserved cargo-interacting regions (CIRs) that enable CCPG1 to recognize and bind aggregation-prone and misfolded ER luminal proteins. Through these domains, CCPG1 directly interacts with ER-localized substrates (e.g., P3H4, 6xIAPP), and with autophagy-related proteins (such as LC3 and FIP200) on the cytoplasmic side, linking targeted cargo recognition to formation and delivery into autophagosomes. CCPG1 expression is upregulated by cellular ER stress and is essential for effective protein quality control, maintaining ER and cellular homeostasis under stress conditions. Loss or dysfunction of CCPG1 impairs selective ER-phagy, leading to accumulation of toxic ER proteins and contributing to various pathologies, including malignancies driven by defective protein degradation. CCPG1 is not currently a direct drug target, but its pathway is under active investigation for understanding and treating diseases of impaired proteostasis or selective autophagy[1][2].

Other names
CCPG1CCPG8CPR8KIAA1254Cell cycle progression restoration protein 8cell cycle progression protein 1cell cycle progression restoration protein 8
02

Mechanism of action

Not established for drugs; however, CCPG1 enables cargo-selective ER-phagy by interacting via its cargo-interacting regions (CIRs) with ER luminal proteins and the autophagic membrane[1][2].

03

Biological functions

ER-phagy (selective autophagy of the ER)Protein quality controlRecognition and removal of misfolded and aggregated ER luminal proteinsMaintenance of cellular and ER-specific homeostasis
04

Disease associations

Cancer (associated with removal of proteins whose accumulation is linked to cancer; e.g., P3H4 is a factor in lung adenocarcinoma and bladder cancer)Other (potential implication in cellular stress response, proteotoxicity, and diseases of protein misfolding)
05

Safety considerations

None reported specifically for CCPG1 targetingAs a critical regulator of ER proteostasis, off-target effects or inhibition could theoretically disrupt protein quality control and normal cellular function
06

Biomarkers

CCPG1 itself may be upregulated in response to ER stressAccumulation or depletion of its cargos (e.g. P3H4, ER chaperones) could be monitored as functional biomarkers

Beyond the preview

Go deeper on Cell cycle progression protein 1 (CCPG1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell cycle progression protein 1 (CCPG1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call